The role of mitophagy in the development of chronic kidney disease

Area of Science:

• Nephrology
• Cell Biology
• Mitochondrial Dynamics

Background:

• Chronic kidney disease (CKD) is a global health issue, with renal fibrosis as its common endpoint.
• Mitochondrial dysfunction in renal tubular epithelial cells (RTECs) is implicated in CKD progression and fibrosis.
• Mitophagy, the selective degradation of damaged mitochondria, is vital for maintaining mitochondrial homeostasis.

Purpose of the Study:

• To review the current research on mitophagy regulation as a potential therapeutic strategy for CKD.
• To elucidate the precise pathogenic mechanisms of mitophagy in CKD-related renal fibrosis.
• To explore how modulating mitophagy impacts CKD progression and patient prognosis.

Main Methods:

• Comprehensive literature review of studies on mitophagy, mitochondrial function, and renal fibrosis in CKD.
• Analysis of existing research on the role of mitophagy in acute kidney injury (AKI) and its extrapolation to CKD.
• Synthesis of data on mitochondrial metabolism, reactive oxygen species (ROS), inflammation, and apoptosis in kidney disease contexts.

Main Results:

• Mitophagy dysregulation is linked to impaired mitochondrial dynamics and exacerbates renal fibrosis in CKD.
• While the role of mitophagy in AKI is understood, its specific mechanisms in CKD remain largely unclear.
• Evidence suggests potential benefits of mitophagy modulation in mitigating renal fibrosis.

Conclusions:

• Targeting mitophagy presents a promising avenue for novel CKD therapies.
• Further systematic investigation is needed to understand mitophagy's precise role and therapeutic potential in CKD.
• Understanding mitophagy regulation could lead to improved CKD treatment strategies and patient outcomes.